EFFECT OF A MONO-AMINOOXIDASE INHIBITOR (NIALAMIDE) ON THYROID ACTIVITY.
D001219:Aspartate Aminotransferases; D001769:Blood; D002395:Catecholamines; D007456:Iodine Isotopes; D008099:Liver; D008660:Metabolism; D008779:Methylthiouracil; D009526:Nialamide; D010336:Pathology; D010600:Pharmacology; D051381:Rats; D012106:Research; D012701:Serotonin; D013961:Thyroid Gland; D013974:Thyroxine; D014116:Toxicology; D014284:Triiodothyronine
D002395:Catecholamines; D007456:Iodine Isotopes; D014284:Triiodothyronine; D012701:Serotonin; D001219:Aspartate Aminotransferases; D013974:Thyroxine; D008779:Methylthiouracil; D009526:Nialamide
ASPARTATE AMINOTRANSFERASE; BLOOD; CATECHOLAMINES; EXPERIMENTAL LAB STUDY; IODINE ISOTOPES; LIVER; METABOLISM; METHYLTHIOURACIL; NIALAMIDE; PATHOLOGY; PHARMACOLOGY; RATS; SEROTONIN; THYROID GLAND; THYROXINE; TOXICOLOGIC REPORT; TRIIODOTHYRONINE